The estimated Net Worth of Adel Mekhail is at least $3.22 Million dollars as of 15 February 2024. Mr. Mekhail owns over 15,549 units of Prestige Consumer Healthcare Inc stock worth over $2,149,958 and over the last 6 years he sold PBH stock worth over $0. In addition, he makes $1,068,260 as Executive Vice President - Sales and Marketing at Prestige Consumer Healthcare Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Mekhail PBH stock SEC Form 4 insiders trading
Adel has made over 2 trades of the Prestige Consumer Healthcare Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 15,549 units of PBH stock worth $582,466 on 15 February 2024.
The largest trade he's ever made was exercising 17,194 units of Prestige Consumer Healthcare Inc stock on 19 May 2023 worth over $519,087. On average, Adel trades about 2,046 units every 17 days since 2019. As of 15 February 2024 he still owns at least 30,230 units of Prestige Consumer Healthcare Inc stock.
You can see the complete history of Mr. Mekhail stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Adel Mekhail biography
Adel Mekhail serves as Executive Vice President - Sales and Marketing of the Company. Adel Mekhail, Executive Vice President, Marketing & Sales, was appointed to the position of Executive Vice President of Marketing & Sales for the Company in May 2019. From April 2017 to July 2018, Mr. Mekhail served as Vice President, Americas at Edgewell Personal Care, a personal care products company. He served as Vice President and General Manager, Private Brands Group and Vice President, Latin America from July 2015 to April 2017 also at Edgewell Personal Care. From November 2013 to July 2015, Mr. Mekhail served as Vice President, Asia Pacific at Energizer, which was acquired by Edgewell. He held other increasingly responsible marketing roles at Energizer from 2003 to 2013. Mr. Mekhail also served in sales and marketing roles for Pfizer and Warner Lambert from 1996 to 2003. In 2000, he moved from Australia to the United States for Pfizer. Mr. Mekhail earned his BS in Pharmaceutical Sciences from Tanta University in Egypt and his MBA from RMIT University in Melbourne, Australia.
What is the salary of Adel Mekhail?
As the Executive Vice President - Sales and Marketing of Prestige Consumer Healthcare Inc, the total compensation of Adel Mekhail at Prestige Consumer Healthcare Inc is $1,068,260. There are 4 executives at Prestige Consumer Healthcare Inc getting paid more, with Ronald Lombardi having the highest compensation of $5,051,680.
How old is Adel Mekhail?
Adel Mekhail is 59, he's been the Executive Vice President - Sales and Marketing of Prestige Consumer Healthcare Inc since 2020. There are 6 older and 9 younger executives at Prestige Consumer Healthcare Inc. The oldest executive at Prestige Consumer Healthcare Inc is James Jenness, 73, who is the Independent Director.
Insiders trading at Prestige Consumer Healthcare Inc
Over the last 20 years, insiders at Prestige Consumer Healthcare Inc have traded over $32,224,266 worth of Prestige Consumer Healthcare Inc stock and bought 60,410 units worth $1,162,754 . The most active insiders traders include Matthew Mannelly, James M Jenness, and Dawn M. Zier. On average, Prestige Consumer Healthcare Inc executives and independent directors trade stock every 62 days with the average trade being worth of $2,469,571. The most recent stock trade was executed by Mary Beth Fritz on 1 March 2024, trading 172 units of PBH stock currently worth $6,908.
What does Prestige Consumer Healthcare Inc do?
at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th
What does Prestige Consumer Healthcare Inc's logo look like?
Complete history of Mr. Mekhail stock trades at Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc executives and stock owners
Prestige Consumer Healthcare Inc executives and other stock owners filed with the SEC include:
-
Ronald Lombardi,
Chairman of the Board, President, Chief Executive Officer -
Ronald M. Lombardi,
Chairman, Pres & CEO -
Christine Sacco,
Chief Financial Officer -
William PPool,
Senior Vice President, General Counsel and Corporate Secretary -
Adel Mekhail,
Executive Vice President - Sales and Marketing -
Christine Sacco,
Chief Financial Officer -
Jeffrey Zerillo,
Senior Vice President, Operations -
Adel Mekhail,
Exec. VP of Marketing & Sales -
William C. P'Pool,
Sr. VP, Gen. Counsel & Corp. Sec. -
Jeffrey Zerillo,
Sr. VP of Operations -
Gary Costley,
Lead Independent Director -
John Byom,
Independent Director -
James Jenness,
Independent Director -
Natale Ricciardi,
Independent Director -
Sheila Hopkins,
Independent Director -
Christopher Coughlin,
Independent Director -
Dawn Zier,
Independent Director -
Mary Beth Fritz,
Sr. VP of Quality & Regulatory Affairs -
Dean Siegal,
Director of Communications -
Philip David Terpolilli,
Director of Investor Relations -
John F. Kelly,
Director -
Lieven Nuyttens,
Senior VP, Operations -
Partners Viii L Pgtcr Golde...,
-
Paul Migaki,
VP Strategic Planning/Canada -
Thomas Hochuli,
Vice President, Operations -
David S Marberger,
Chief Financial Officer -
Timothy Connors,
Chief Marketing Officer -
John Parkinson,
Senior VP- International -
Christopher Heye,
See remarks -
Carl J Johnson,
Director -
Samuel C Cowley,
General Counsel, VP Bus. Dev. -
James E Kelly,
Senior VP - Marketing -
Mark Pettie,
Chairman of the Board and CEO -
Ronald B Gordon,
Director -
Charles Schrank,
Senior V.P. of Marketing -
Peter Anderson,
Chief Financial Officer -
David Talbert,
Senior Vice President, Sales -
Gerard Butler,
Chief Sales Officer -
Co Invest Ii Lpgtcr Golder ...,
-
Fund Viii Lpgtcr Partners V...,
-
Jean A Boyko,
SVP, Quality & Reg. Affairs -
John Byom,
Director -
Eric S. Klee,
Secretary and General Counsel -
Peter Mann,
Chief Executive Officer -
L Dick Buell,
Director -
Mezzanine Partners Lpgtcr P...,
-
Frank Palantoni,
President and COO -
Eric Millar,
Senior V.P. of Operations -
Charles Hinkaty,
Director -
Matthew Mannelly,
President and CEO -
Michael Fink,
Senior V.P. of Marketing -
Raymond Silcock,
Director -
Paul A. Hennessey,
Vice President, Operations -
Patrick Lonergan,
Director -
Vincent J Hemmer,
Director -
Mezzanine Partners Lpgtcr G...,
-
Fund Viii/B L Pgtcr Partner...,
-
Golder Rauner Ii Llc Gtcr,
10% owner -
Capital Partners L Pgtcr Me...,
-
David Donnini,
Director -
Charles Jolly,
Secretary & General Counsel -
Celeste A. Clark,
Director -
James D Arecca,
Director -
William P'pool,
See Remarks -
Mary Beth Fritz,
SVP Quality & Regulatory